The patient journey in chronic coronary syndromes with/without obstructive coronary arteries

Sarena La1,2,3, Rosanna Tavella1,2,3, Jing Wu1

  • 1School of Medicine, Faculty of Health Sciences, The University of Adelaide, Adelaide, SA 5000, Australia.

Insights

Patients with angina and no obstructive coronary artery disease (ANOCA) have similar symptoms to those with obstructive coronary artery disease (CAD) but face a significant diagnostic and treatment gap post-angiography.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Patient Outcomes

Background:

  • Management pathways for obstructive coronary artery disease (CAD) are established.
  • The clinical and diagnostic journey for patients with angina with no obstructive coronary artery disease (ANOCA) is poorly understood due to limited data.

Purpose of the Study:

  • To compare the clinical presentation, diagnostic assessment, and 12-month patient-reported outcome measures (PROMs) of patients with ANOCA versus obstructive CAD.
  • To evaluate three-year composite Major Adverse Cardiovascular Events (MACE) in ANOCA versus obstructive CAD patients.

Main Methods:

  • Utilized data from the Coronary Angiogram Database of South Australia (CADOSA) registry.
  • Included 2,285 ANOCA patients and 4,087 obstructive CAD patients between 2012-2018.
  • Compared clinical presentation, diagnostic workup, PROMs, and MACE.

Main Results:

  • Pre-angiography, ANOCA and obstructive CAD patients had indistinguishable chest pain and ischemic markers.
  • ANOCA patients were younger, more likely female, and had fewer cardiac risk factors.
  • Post-angiography, ANOCA patients were less likely to receive a cardiac diagnosis or anti-anginal therapy, despite similar persistent angina rates.

Conclusions:

  • The pre-angiography clinical presentation and diagnostic markers for ANOCA and obstructive CAD are similar.
  • A significant diagnostic and treatment gap exists for ANOCA patients after invasive coronary angiography.
  • Addressing this gap is crucial for improving care for ANOCA patients.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K